Sticky post
Cann Group Limited (ASX: CAN) has been granted import permits by the drug control section of the Therapeutic Goods Administration (TGA) that enables the company to commence the import of genetics and cannabis oils from its Canadian partners. The receipt … Continue reading Cann Group Announces Receipt of Import Permits for Genetics and Cannabis Oil
AusCann continues to demonstrate strong operational momentum with the granting of the final licence required for operations in Tasmania, the approval in Chile to plant its second crop, and post the quarter, an agreement with API to establish Australia wide … Continue reading AusCann Provides Quarterly Report for December 2017
MMJ PhytoTech Limited (ASX: MMJ) advised that it has entered into an agreement to acquire a strategic stake in private, Canadian-based healthcare company Dosecann Inc., via the proposed placement of C$2.5 million in secured convertible debenture units . Strategically, the … Continue reading MMJ Phytotech Announces Acquition of Strategic Position in Dosecann Inc
AusCann Group Holdings Ltd (ASX:AC8) announced that it has entered into a Heads of Agreement (HoA) with ASX listed Australian Pharmaceutical Industries Limited (ASX:API) to form a wholesale agreement for the distribution of AusCann’s cannabinoid medicines throughout Australia. The collaboration … Continue reading AusCann Group Holdings Signs HoA with Leading Wholesale Distributor in Australia
Creso Pharma Limited (ASX:CPH, the “Company” or “Creso”) is pleased to announce it has secured a commercialisation agreement with UK-based Precision Healthcare Ltd to market and distribute Creso Pharma’s cannaQIX®10 and 50 hemp-based human health nutraceutical products in the UK. … Continue reading Creso Pharma Signs Commercialisation Agreement for UK Launch of CannaQIX
Creso Pharma Limited (ASX:CPH) announced that it has formally launched its new joint venture company with LGC Capital Ltd (TSXV: LG) and Baltic Beer Company Ltd (“Baltic Beer Company”) to capitalise on the fast-growing cannabis and hempderived beverage markets. The … Continue reading Creso Pharma Announces Launch of JV for Cannabis-Derived Beverage Market
The Hydroponics Company Limited (ASX:THC) advises that it welcomes the announcement from Health Minister Greg Hunt allowing for the exportation of medicinal cannabis. THC believes that this initiative will foster the development of the local medicinal cannabis industry and expects … Continue reading The Hydroponics Company Provides Product Update
Cann Group Limited (ASX: CAN) today welcomed the Federal Government’s announcement that Australian producers of medicinal cannabis will be permitted to export product to overseas markets. Cann Group CEO Peter Crock said the decision to allow exports will lead to … Continue reading Cann Group Advises on Federal Government Announcement on Medicinal Cannabis Export
AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) is pleased to announce that its 50:50 Chilean joint venture, DayaCann, has commenced planting of its second medicinal cannabis crop, following the grant of its cultivation licence as announced on 22 November … Continue reading AusCann Group Holdings Plants Second Crop in Chile
Cann Group Limited (ASX: CAN) (“Cann Group” or “the Company”) has successfully completed a Placement of fully paid ordinary shares in the Company (“New Shares”) at $2.50 each (“Placement Price”) to institutional, sophisticated and professional investors which has raised $58.7 … Continue reading Cann Group Completes Placement Successfully
